IP Verse

Pharmaceutical Compositions Having Desirable Bioavailability

EP3042646

ALCON RESEARCH, LTD.
Application Number
EP15202422A
Filing Date
Mar 13, 2009
Status
Revoked
Jul 19, 2024
Grant Date
May 10, 2017
External Links
Slate, Register

Biblio Summary

The patent EP3042646B1 was granted on May 10, 2017 by Alcon Research, Ltd. The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 6 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ACTREVO GMBHFeb 12, 2018WITHDRAWN
GENERICS UKFeb 9, 2018ADMISSIBLE
GENERICS [UK] LIMITED (TRADING AS MYLAN)Feb 9, 2018ADMISSIBLE
ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.Feb 9, 2018ADMISSIBLE
BAUSCH & LOMB INCORPORATEDFeb 7, 2018ADMISSIBLE
INSTONE, TERRY/READ, HOWARD GRAHAM/APPLEYARD LEES IP LLPFeb 1, 2018ADMISSIBLE

More Opposed Patents of Alcon Research, Ltd.

The table below shows the patents of Alcon Research, Ltd. that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3178421Optimized Pneumatic Drive LinesAug 11, 20211
EP3045164Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesApr 15, 20201
EP2420223Aqueous Pharmaceutical Compositions Containing Borate-Polyol ComplexesJul 19, 20172

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents